Evaluation of mupA EVIGENE Assay for Determination of High-Level Mupirocin Resistance in Staphylococcus aureus

Mupirocin is widely used to decolonize patients carrying Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA). The aim of this study was to determine the presence of high-level mupirocin resistance by a new commercially available mupA genotypic diagnostic product, mupA EVIGENE as...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Clinical Microbiology 2010-11, Vol.48 (11), p.4253-4255
Hauptverfasser:	Rasmussen, Anne K.I, Skov, Robert L, Venezia, Richard A, Johnson, Jennifer K, Stender, Henrik
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Bacterial Proteins - genetics Bacteriology Biological and medical sciences DNA, Bacterial - genetics Drug Resistance, Bacterial Fundamental and applied biological sciences. Psychology Genotype Humans Microbial Sensitivity Tests - methods Microbiology Miscellaneous Mupirocin - pharmacology Nuclear Proteins - genetics Nucleic Acid Hybridization - methods Sensitivity and Specificity Staphylococcus aureus Staphylococcus aureus - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Mupirocin is widely used to decolonize patients carrying Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA). The aim of this study was to determine the presence of high-level mupirocin resistance by a new commercially available mupA genotypic diagnostic product, mupA EVIGENE assay (AdvanDx).
ISSN:	0095-1137 1098-660X
DOI:	10.1128/JCM.00088-10